Drug record
What four public record sets show for escitalopram. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.039 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $158.6 million | Details |
| FDA recall records | 2 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Escitalopram 10 Mg Tablet: pharmacies pay about $0.039 each, or $1.17 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| ESCITALOPRAM 10 MG TABLET | Generic | $0.039 per each | $1.17 | Oct 21, 2026 |
| ESCITALOPRAM 15 MG CAPSULE | Generic | $5.51 per each | $165.40 | Oct 21, 2026 |
| ESCITALOPRAM 20 MG TABLET | Generic | $0.063 per each | $1.90 | Oct 21, 2026 |
| ESCITALOPRAM 5 MG TABLET | Generic | $0.043 per each | $1.29 | Oct 21, 2026 |
| ESCITALOPRAM OXALATE 5 MG/5 ML | Generic | $0.161 per mL | — | Oct 21, 2026 |
| LEXAPRO 10 MG TABLET | Brand | $15.43 per each | $462.77 | Oct 21, 2026 |
| LEXAPRO 20 MG TABLET | Brand | $16.11 per each | $483.16 | Oct 21, 2026 |
| LEXAPRO 5 MG TABLET | Brand | $14.74 per each | $442.30 | Jan 2, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $158.6 million for the 2 products below. That is up 0% from $158.2 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Escitalopram Oxalate Escitalopram Oxalate | $141.0 million | 2,725,607 | $11.11 | $51.73 | $137.3 million |
| Lexapro Escitalopram Oxalate | $17.6 million | 4,182 | $867.93 | $4,209.11 | $20.9 million |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 2 recall records that name escitalopram in the product description (1 Class II · 1 Class III).
Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01
Reason: Labeling: Incorrect or Missing Lot and/or Expiration Date
ESCITALOPRAM, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093585001.
Reason: Labeling: Label Mixup: ESCITALOPRAM, Tablet, 5 mgmay have potentially been mislabeled as the following drug: SODIUM CHLORIDE, Tablet, 1 gm, NDC 00223176001, Pedigree: W003707, EXP: 6/25/2014.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for escitalopram. This page is public-record information, not medical advice.